We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.17B
AUM Growth
-$6.39M
Cap. Flow
+$112M
Cap. Flow %
5.16%
Top 10 Hldgs %
36.67%
Holding
3,684
New
390
Increased
1,388
Reduced
1,049
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 12.44%
2 Healthcare 9.68%
3 Financials 8.68%
4 Consumer Discretionary 4.31%
5 Communication Services 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIG
3001
DELISTED
Big Lots, Inc.
BIG
$1K ﹤0.01%
57
-136
-70% -$2.93K
LL
3002
DELISTED
LL Flooring Holdings, Inc.
LL
$1K ﹤0.01%
+108
New +$970
CATC
3003
DELISTED
CAMBRIDGE BANCORP
CATC
$1K ﹤0.01%
18
EVBG
3004
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1K ﹤0.01%
46
-148
-76% -$4.86K
MODN
3005
DELISTED
MODEL N, INC.
MODN
$1K ﹤0.01%
42
-218
-84% -$6.3K
OMIC
3006
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1K ﹤0.01%
+11
New +$1.15K
LICY
3007
DELISTED
Li-Cycle Holdings Corp.
LICY
$1K ﹤0.01%
+31
New +$1.69K
KAMN
3008
DELISTED
Kaman Corp
KAMN
$1K ﹤0.01%
25
-3
-11% -$94
VIEW
3009
DELISTED
View, Inc. Class A Common Stock
VIEW
$1K ﹤0.01%
17
CYT
3010
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1K ﹤0.01%
464
EXPR
3011
DELISTED
Express, Inc.
EXPR
$1K ﹤0.01%
+32
New +$1.09K
GOL
3012
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$1K ﹤0.01%
+241
New +$887
SFE
3013
DELISTED
Safeguard Scientifics, Inc.
SFE
$1K ﹤0.01%
+250
New +$1K
VRTV
3014
DELISTED
VERITIV CORPORATION
VRTV
$1K ﹤0.01%
9
-4
-31% -$476
SONX
3015
DELISTED
Sonendo, Inc.
SONX
$1K ﹤0.01%
581
WE
3016
DELISTED
WeWork Inc.
WE
$1K ﹤0.01%
+8
New +$1.44K
NEX
3017
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$1K ﹤0.01%
138
FOCS
3018
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$1K ﹤0.01%
37
-3
-8% -$114
KDNY
3019
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
40
+14
+54% +$281
GRNA
3020
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$1K ﹤0.01%
+347
New +$908
XM
3021
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$1K ﹤0.01%
52
ROCC
3022
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1K ﹤0.01%
37
-2
-5% -$70
BSX.PRA
3023
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
$1K ﹤0.01%
5
MNTV
3024
DELISTED
Momentive Global Inc. Common Stock
MNTV
$1K ﹤0.01%
228
+227
+22,700% +$1.76K
SUMO
3025
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$1K ﹤0.01%
67
+33
+97% +$263

Similar funds

Parallel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Parallel Advisors held 3,684 positions worth $2.17B, down 0.29% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $112M of net new capital in Q3 2022, opening 390 new positions and adding to 1,388 existing holdings. Its largest new stake was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $24.4M trimmed.

  • Parallel Advisors's largest Q3 2022 buy was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
  • Parallel Advisors added most to iShares International Select Dividend ETF in Q3 2022, an estimated $42.9M increase.
  • Parallel Advisors's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $24.4M.
  • Parallel Advisors fully exited Sanderson Farms Inc in Q3 2022, selling an estimated $503K.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.17B portfolio in Q3 2022.
  • Parallel Advisors opened 390 new positions and closed 222 in Q3 2022.
  • Parallel Advisors's portfolio value fell 0.29% quarter-over-quarter to $2.17B.

Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.